TDRD9 Antikörper (AA 801-900)

Produktnummer ABIN1385847

Dieses Anti-TDRD9-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von TDRD9 in ELISA, IF (cc), IF (p) und IHC (fro). Geeignet für Human.

Kurzübersicht für TDRD9 Antikörper (AA 801-900) (ABIN1385847)

Target: TDRD9 (Tudor Domain Containing 9 (TDRD9))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TDRD9 Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-TDRD9 Antikörper

Bindungsspezifität: AA 801-900

Homologie: Human,Mouse,Rat,Dog,Cow,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human TDRD9/HIG1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu TDRD9

Target: TDRD9 (Tudor Domain Containing 9 (TDRD9))

Andere Bezeichnung: TDRD9/HIG1

Hintergrund:

Synonyms: C14orf75, chromosome 14 open reading frame 75, HIG 1, Hypoxia inducible HIG 1, MGC135025, Putative ATP dependent RNA helicase TDRD9, Putative ATP-dependent RNA helicase TDRD9, TDRD 9, Tdrd9, TDRD9_HUMAN , Tudor domain containing 9, Tudor domain containing protein 9, Tudor domain-containing protein 9.

Background: Probable ATP-binding RNA helicase which plays a central role during spermatogenesis by repressing transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Its association with PIWIL4 and the piP-bodies suggests a participation in the secondary piRNAs metabolic process.

Gen-ID: 122402